73 related articles for article (PubMed ID: 11312622)
1. Risk adapted transmission prophylaxis to prevent vertical HIV-1 transmission: effectiveness and safety of an abbreviated regimen of postnatal oral zidovudine.
Neubert J; Pfeffer M; Borkhardt A; Niehues T; Adams O; Bolten M; Reuter S; Stannigel H; Laws HJ
BMC Pregnancy Childbirth; 2013 Jan; 13():22. PubMed ID: 23347580
[TBL] [Abstract][Full Text] [Related]
2. Use of zidovudine-sparing HAART in pregnant HIV-infected women in Europe: 2000-2009.
Tariq S; Townsend CL; Cortina-Borja M; Duong T; Elford J; Thorne C; Tookey PA; ;
J Acquir Immune Defic Syndr; 2011 Aug; 57(4):326-33. PubMed ID: 21499113
[TBL] [Abstract][Full Text] [Related]
3. Elevated frequencies of micronucleated erythrocytes in infants exposed to zidovudine in utero and postpartum to prevent mother-to-child transmission of HIV.
Witt KL; Cunningham CK; Patterson KB; Kissling GE; Dertinger SD; Livingston E; Bishop JB
Environ Mol Mutagen; 2007; 48(3-4):322-9. PubMed ID: 17358032
[TBL] [Abstract][Full Text] [Related]
4. The second generation of HIV-1 vertically exposed infants: a case series from the Italian Register for paediatric HIV infection.
Calitri C; Gabiano C; Galli L; Chiappini E; Giaquinto C; Buffolano W; Genovese O; Esposito S; Bernardi S; De Martino M; Tovo PA;
BMC Infect Dis; 2014 May; 14():277. PubMed ID: 24885649
[TBL] [Abstract][Full Text] [Related]
5. Preventive measures to avoid vertical transmission in untreated pregnant women with HIV/AIDS.
Rincón Franco S; Uriel M; Rodríguez LM; Romero Infante XC
BMJ Case Rep; 2020 Mar; 13(3):. PubMed ID: 32213503
[TBL] [Abstract][Full Text] [Related]
6. Zidovudine adherence in persons with AIDS. The relation of patient beliefs about medication to self-termination of therapy.
Smith MY; Rapkin BD; Morrison A; Kammerman S
J Gen Intern Med; 1997 Apr; 12(4):216-23. PubMed ID: 9127225
[TBL] [Abstract][Full Text] [Related]
7. Risk Factors for Adverse Birth Outcomes in the PROMISE 1077BF/1077FF Trial.
Sebikari D; Farhad M; Fenton T; Owor M; Stringer JSA; Qin M; Chakhtoura N; Chi BH; Saidi F; Nevrekar N; Violari A; Chipato T; McIntyre JA; Moodley D; Taha TE; Theron G; Fowler MG
J Acquir Immune Defic Syndr; 2019 Aug; 81(5):521-532. PubMed ID: 31295174
[TBL] [Abstract][Full Text] [Related]
8. Pregnancy Management in HIV Viral Controllers: Twenty Years of Experience.
Short CS; Byrne L; Hagan-Bezgin A; Quinlan RA; Anderson J; Brook G; De Alwis O; de Ruiter A; Farrugia P; Fidler S; Hamlyn E; Hartley A; Murphy S; Noble H; Oomeer S; Roedling S; Rosenvinge M; Rubinstein L; Shah R; Singh S; Thorne E; Toby M; Wait B; Sarner L; Taylor GP
Pathogens; 2024 Apr; 13(4):. PubMed ID: 38668263
[TBL] [Abstract][Full Text] [Related]
9. Thirty years of HIV pregnancies in French Guiana: prevention successes and remaining obstetrical challenges.
Nacher M; Blanc J; Rabier S; Lucarelli A; Adenis A; Basurko C; Louis A; Dotou D; Leneuve M; Osei L; Elenga N; Hcini N
Front Glob Womens Health; 2023; 4():1264837. PubMed ID: 38234591
[TBL] [Abstract][Full Text] [Related]
10. In utero and peripartum antiretroviral exposure as predictor of cognition in 6- to 10-year-old HIV-exposed Ugandan children - a prospective cohort study.
Ezeamama AE; Zalwango SK; Sikorskii A; Tuke R; Musoke PM; Giordani B; Boivin MJ
HIV Med; 2021 Aug; 22(7):592-604. PubMed ID: 33860626
[TBL] [Abstract][Full Text] [Related]
11. Improving universal prenatal screening for human immunodeficiency virus.
Anderson BL; Simhan HN; Landers DV
Infect Dis Obstet Gynecol; 2004; 12(3-4):115-20. PubMed ID: 15763910
[TBL] [Abstract][Full Text] [Related]
12. HIV infection and zidovudine use in childbearing women.
Sia J; Paul S; Martin RM; Cross H
Pediatrics; 2004 Dec; 114(6):e707-12. PubMed ID: 15545619
[TBL] [Abstract][Full Text] [Related]
13. Short course zidovudine maternal treatment in HIV-1 vertical transmission: randomized controlled multicenter trial.
Limpongsanurak S; Thaithumyanon P; Chaithongwongwatthana S; Thisyakorn U; Ruxrungtham K; Kongsin P; Tarounotai U; Chantheptaewan N; Triratwerapong T; Ubolyam S; Phanuphak P; Virutamasen P; Hanwanich M; Hawanon P; Chulasugondha P
J Med Assoc Thai; 2001 Jun; 84 Suppl 1():S338-45. PubMed ID: 11529355
[TBL] [Abstract][Full Text] [Related]
14. Update on vertical HIV transmission.
Groginsky E; Bowdler N; Yankowitz J
J Reprod Med; 1998 Aug; 43(8):637-46. PubMed ID: 9749412
[TBL] [Abstract][Full Text] [Related]
15. Genotypic resistance tests for the management of the HIV-infected pregnant woman.
Bassetti D; Cargnel A
Scand J Infect Dis Suppl; 2003; 106():70-4. PubMed ID: 15000589
[TBL] [Abstract][Full Text] [Related]
16. Vertical HIV-1 transmission: prophylaxis and paediatric follow-up.
Carneiro M; Sanchéz A; Maneiro P; Angelosante W; Pérez C; Valleé M
Placenta; 2001 Apr; 22 Suppl A():S13-8. PubMed ID: 11312622
[TBL] [Abstract][Full Text] [Related]
17. Maternal 12-month response to antiretroviral therapy following prevention of mother-to-child transmission of HIV type 1, Ivory Coast, 2003-2006.
Coffie PA; Ekouevi DK; Chaix ML; Tonwe-Gold B; Clarisse AB; Becquet R; Viho I; N'dri-Yoman T; Leroy V; Abrams EJ; Rouzioux C; Dabis F
Clin Infect Dis; 2008 Feb; 46(4):611-21. PubMed ID: 18197758
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
